Loading...

Christina J. Azevedo, MD

TitleAssistant Professor of Clinical Neurology
InstitutionUniversity of Southern California
DepartmentNeurology
AddressHCT 1520 San Pablo Street
Health Sciences Campus
Los Angeles CA 90033-9405
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Azevedo C, Cen SY, Khadka S, Liu S, Kornak J, Shi Y, Zheng L, Hauser SL, Pelletier D. Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease. Ann Neurol. 2018 Feb; 83(2):223-234. PMID: 29328531.
      View in: PubMed
    2. Azevedo C, Jaberzadeh A, Pelletier D. New Concepts Related to Disease Appreciation in Multiple Sclerosis. Neurol Clin. 2018 Feb; 36(1):119-133. PMID: 29157393.
      View in: PubMed
    3. Zeydan B, Gu X, Atkinson EJ, Keegan BM, Weinshenker BG, Tillema JM, Pelletier D, Azevedo C, Lebrun-Frenay C, Siva A, Okuda DT, Kantarci K, Kantarci OH. Cervical spinal cord atrophy: An early marker of progressive MS onset. Neurol Neuroimmunol Neuroinflamm. 2018 Mar; 5(2):e435. PMID: 29435472.
      View in: PubMed
    4. Azevedo C, Pelletier D. Whole-brain atrophy: ready for implementation into clinical decision-making in multiple sclerosis? Curr Opin Neurol. 2016 06; 29(3):237-42. PMID: 27070219.
      View in: PubMed
    5. Nourbakhsh B, Azevedo C, Maghzi AH, Spain R, Pelletier D, Waubant E. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis. J Neurol Sci. 2016 Jul 15; 366:229-233. PMID: 27288812.
      View in: PubMed
    6. Kantarci OH, Lebrun C, Siva A, Keegan MB, Azevedo C, Inglese M, Tintoré M, Newton BD, Durand-Dubief F, Amato MP, De Stefano N, Sormani MP, Pelletier D, Okuda DT. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome. Ann Neurol. 2016 Feb; 79(2):288-94. PMID: 26599831.
      View in: PubMed
    7. Nourbakhsh B, Azevedo C, Nunan-Saah J, Maghzi AH, Spain R, Pelletier D, Waubant E. Longitudinal associations between brain structural changes and fatigue in early MS. Mult Scler Relat Disord. 2016 Jan; 5:29-33. PMID: 26856940.
      View in: PubMed
    8. Azevedo C, Overton E, Khadka S, Buckley J, Liu S, Sampat M, Kantarci O, Lebrun Frenay C, Siva A, Okuda DT, Pelletier D. Early CNS neurodegeneration in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm. 2015 Jun; 2(3):e102. PMID: 25884012; PMCID: PMC4396526.
    9. Khan OI, Azevedo C, Hartshorn AL, Montanye JT, Gonzalez JC, Natola MA, Surgenor SD, Morse RP, Nordgren RE, Bujarski KA, Holmes GL, Jobst BC, Scott RC, Thadani VM. A comparison of continuous video-EEG monitoring and 30-minute EEG in an ICU. Epileptic Disord. 2014 Dec; 16(4):439-48. PMID: 25498516.
      View in: PubMed
    10. Bhargava P, Cassard S, Steele SU, Azevedo C, Pelletier D, Sugar EA, Waubant E, Mowry EM. The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis. Contemp Clin Trials. 2014 Nov; 39(2):288-93. PMID: 25311447.
      View in: PubMed
    11. Azevedo C, Kornak J, Chu P, Sampat M, Okuda DT, Cree BA, Nelson SJ, Hauser SL, Pelletier D. In vivo evidence of glutamate toxicity in multiple sclerosis. Ann Neurol. 2014 Aug; 76(2):269-78. PMID: 25043416; PMCID: PMC4142752.
    12. Riley C, Azevedo C, Bailey M, Pelletier D. Clinical applications of imaging disease burden in multiple sclerosis: MRI and advanced imaging techniques. Expert Rev Neurother. 2012 Mar; 12(3):323-33. PMID: 22364331.
      View in: PubMed